Cargando…

Novel AF1q/MLLT11 favorably affects imatinib resistance and cell survival in chronic myeloid leukemia

Tyrosine kinase inhibitor treatment of chronic myeloid leukemia (CML) has demonstrated beneficial effects. However, resistance to tyrosine kinase inhibitors and disease relapse are still a challenge for CML therapy. In this study, we analyzed bone marrow samples from 149 CML patients and 15 control...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wei, Ji, Min, Lu, Fei, Pang, Yihua, Dong, Xin, Zhang, Jingru, Li, Peng, Ye, Jingjing, Zang, Shaolei, Ma, Daoxin, Ji, Chunyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113287/ https://www.ncbi.nlm.nih.gov/pubmed/30154435 http://dx.doi.org/10.1038/s41419-018-0900-7

Ejemplares similares

Involvement of AF1q/MLLT11 in the progression of ovarian cancer
por: Tiberio, Paola, et al.
Publicado: (2017)

MLLT11/AF1q boosts oncogenic STAT3 activity through Src-PDGFR tyrosine kinase signaling
por: Park, Jino, et al.
Publicado: (2016)

Subclones of bone marrow CD34(+) cells in acute myeloid leukemia at diagnosis confer responses of patients to induction chemotherapy
por: Jia, Ruinan, et al.
Publicado: (2022)

The First Case of Acute Myeloid Leukemia With t(10;11)(p13;q21);PICALM-MLLT10 Rearrangement Presenting With Extensive Skin Involvement
por: Park, Min-Seung, et al.
Publicado: (2023)

Role of CDH23 as a prognostic biomarker and its relationship with immune infiltration in acute myeloid leukemia
por: Yang, Jiao, et al.
Publicado: (2022)

Childhood acute myeloid leukemia with 5q deletion and HNRNPH1-MLLT10 fusion: the first case report
por: Kudo, Ko, et al.
Publicado: (2022)

Early BCR-ABL1 decline in imatinib-treated patients with chronic myeloid leukemia: results from a multicenter study of the Chinese CML alliance
por: Zhang, Jingru, et al.
Publicado: (2018)

Restoration of miR-23a expression by chidamide sensitizes CML cells to imatinib treatment with concomitant downregulation of CRYAB
por: Zhu, Xunxun, et al.
Publicado: (2022)

The Leukemia-Associated Mllt10/Af10-Dot1l Are Tcf4/β-Catenin Coactivators Essential for Intestinal Homeostasis
por: Mahmoudi, Tokameh, et al.
Publicado: (2010)

The Elongation Complex Components BRD4 and MLLT3/AF9 Are Transcriptional Coactivators of Nuclear Retinoid Receptors
por: Flajollet, Sébastien, et al.
Publicado: (2013)

Three-way Translocation of MLL/MLLT3, t(1;9;11)(p34.2;p22;q23), in a Pediatric Case of Acute Myeloid Leukemia
por: Jun, Kyung Ran, et al.
Publicado: (2011)

Correction: The Leukemia-Associated Mllt10/Af10-Dot1l Are Tcf4/β-Catenin Coactivators Essential for Intestinal Homeostasis
por: Mahmoudi, Tokameh, et al.
Publicado: (2017)

Wnt signaling is involved in 6-benzylthioinosine-induced AML cell differentiation
por: Zang, Shaolei, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells and γδT17 Cells Contribute to the Development of Gastric MALT Lymphoma in H. felis-Infected Mice
por: Zhao, Yanan, et al.
Publicado: (2020)

SMG1 Acts as a Novel Potential Tumor Suppressor with Epigenetic Inactivation in Acute Myeloid Leukemia
por: Du, Yahui, et al.
Publicado: (2014)

Novel Agent Nitidine Chloride Induces Erythroid Differentiation and Apoptosis in CML Cells through c-Myc-miRNAs Axis
por: Liu, Na, et al.
Publicado: (2015)

A Case of Therapy-related Acute Lymphoblastic Leukemia with t(11;19)(q23;p13.3) and MLL/MLLT1 Gene Rearrangement
por: Yoo, Byong-Joon, et al.
Publicado: (2011)

B-Cell Chronic Lymphocytic Leukemia with 11q22.3 Rearrangement in Patient with Chronic Myeloid Leukemia Treated with Imatinib
por: Lewandowski, Krzysztof, et al.
Publicado: (2016)

Mllt11 Regulates Migration and Neurite Outgrowth of Cortical Projection Neurons during Development
por: Stanton-Turcotte, Danielle, et al.
Publicado: (2022)

Mllt10 knockout mouse model reveals critical role of Af10-dependent H3K79 methylation in midfacial development
por: Ogoh, Honami, et al.
Publicado: (2017)

Identification of the novel prognostic biomarker, MLLT11, reveals its relationship with immune checkpoint markers in glioma
por: Chen, Long, et al.
Publicado: (2022)

MLL-AF9 and MLL-AF4 oncofusion proteins bind a distinct enhancer repertoire and target the RUNX1 program in 11q23 acute myeloid leukemia
por: Prange, K H M, et al.
Publicado: (2017)

FZD7 regulates BMSCs-mediated protection of CML cells
por: Liu, Na, et al.
Publicado: (2015)

A Rare t(9;22;16)(q34;q11;q24) Translocation in Chronic Myeloid Leukemia for Which Imatinib Mesylate Was Effective: A Case Report
por: Manabe, Masahiro, et al.
Publicado: (2011)

DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10–FGFR2 signaling
por: Yu, Shuang, et al.
Publicado: (2022)

AF10 (MLLT10) prevents somatic cell reprogramming through regulation of DOT1L-mediated H3K79 methylation
por: Uğurlu-Çimen, Deniz, et al.
Publicado: (2021)

Imatinib in Chronic Myeloid Leukemia: an Overview
por: Sacha, Tomasz
Publicado: (2014)

Three-way Philadelphia translocation t(9;10;22)(q34;p11.2;q11.2) as a secondary abnormality in an imatinib mesylate-resistant chronic myeloid leukemia patient
por: AL-ACHKAR, WALID, et al.
Publicado: (2013)

Neuropathy correlated with imbalanced Foxp3/IL-17 in bone marrow microenvironment of patients with acute myeloid leukemia
por: Chen, Chen, et al.
Publicado: (2016)

Molecular studies reveal MLL-MLLT10/AF10 and ARID5B-MLL gene fusions displaced in a case of infantile acute lymphoblastic leukemia with complex karyotype
por: Hiwatari, Mitsuteru, et al.
Publicado: (2017)

High Expression of CLEC11A Predicts Favorable Prognosis in Acute Myeloid Leukemia
por: Yin, Chengliang, et al.
Publicado: (2021)

MicroRNA-411 Downregulation Enhances Tumor Growth by Upregulating MLLT11 Expression in Human Bladder Cancer
por: Jin, Honglei, et al.
Publicado: (2018)

Discovery of an MLLT1/3 YEATS Domain Chemical Probe
por: Moustakim, Moses, et al.
Publicado: (2018)

Imatinib in chronic myeloid leukemia elderly patients
por: Gugliotta, Gabriele, et al.
Publicado: (2011)

FLT3(N676K) drives acute myeloid leukemia in a xenograft model of KMT2A-MLLT3 leukemogenesis
por: Hyrenius-Wittsten, Axel, et al.
Publicado: (2019)

Characterization of hsa_circ_0004277 as a New Biomarker for Acute Myeloid Leukemia via Circular RNA Profile and Bioinformatics Analysis
por: Li, Wei, et al.
Publicado: (2017)

Acute Basophilic Leukemia Arising from Chronic Myeloid Leukemia with +8, I(17q)(q10) and der(22)t(9;22) After Imatinib Therapy
por: Shan, Peng, et al.
Publicado: (2023)

Successful Rechallenge with Imatinib in a Patient with Chronic Myeloid Leukemia Who Previously Experienced Imatinib Mesylate Induced Pneumonitis
por: Go, Seong Woo, et al.
Publicado: (2013)

The Alteration and Clinical Significance of Th22/Th17/Th1 Cells in Patients with Chronic Myeloid Leukemia
por: Chen, Ping, et al.
Publicado: (2015)

The Partial Duplication of the 5′ Segment of KMT2A Revealed KMT2A-MLLT10 Rearrangement in a Boy with Acute Myeloid Leukemia
por: Fukushima, Hiroko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_84se8skgsnbb8sglib85j3ce28